Note: Ingredients listed on restricted chemical lists
EC/CAS
200-578-6/64-17-5
Name of the chemical
Ethanol
Concentration
≥25-≤50
EC/CAS
200-661-7/67-63-0
Name of the chemical
Propan-2-ol
Concentration
≥10-<20
EC/CAS
201-083-8/78-10-4
Name of the chemical
Tetraethyl orthosilicate
Concentration
≤10
General Information
Revision date
2025-12-08
Product name
TEKNOZINC SS SILICATE PART
1.2.1 Relevant identified uses
Paint
Emergency telephone
+353 (0)1 809 2166, +353 (0)1 809 2566
Icons in SDS
Company Information
company name
Teknos Group Oy
e-mail address of the competent person responsible for the Safety Data Sheet
Prod-safe@teknos.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H225, H319
Hazard statements
Code
Statements
H225
Highly Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
1272/2008] Classification of the substance or mixture
Product definition
Mixture
Signal word
Danger
Hazard statements
H225 - Highly flammable liquid and vapour. H319 - Causes serious eye irritation.
Prevention
P280 - Wear eye or face protection. P210 - Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking.
Response
P305 + P351 + P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337 + P313 - If eye irritation persists: Get medical advice or attention.
Storage
Not applicable.
Disposal
P501 - Dispose of contents and container in accordance with all local, regional, national and international regulations.
2.3 Other hazards
Product meets the criteria for PBT or vPvB according : This mixture does not contain any substances that are assessed to be a PBT or a vPvB.
Other hazards which do not result in classification
None known.
2.1 Classification of the substance or mixture
Product definition : Mixture Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS] Flam. Liq. 2, H225 Eye Irrit. 2, H319 The product is classified as hazardous according to Regulation (EC) 1272/2008 as amended. See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.
